Asklepios BioPharmaceutical Company
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Industry:
Gene Therapy
Technology:
Neurological Disorders
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Headquarters:
Chapel Hill, North Carolina, United States
Founded Date:
2001